PO-012 Pre-clinical insight into how platelet count affects the activity of HDACi resminostat in combination with the multi-kinase inhibitor sorafenib in HCC

Autor: Streubel, G., Schrepfer, S., Parnitzke, U., Krauss, R., Borgmann, M., Hamm, S.
Zdroj: In ESMO Open 30 June-3 July 2018 3 Supplement 2:A231-A232
Databáze: ScienceDirect